Posts by Sandra Ansanay-Alex
Leucine project: a new hub for life sciences in Lausanne
New working spaces at Biopôle Campus Lausanne Biopôle SA, in collaboration with CPEV, is developing the Leucine Building, a new multi-tenant space for companies active in life sciences. It will be operational early 2023. It consists of laboratory and office space that can be customised to its tenants’ needs. Three full floors of up to…
Read MorePhytlSigns raises CHF 500 000 for a plant monitoring system
The ‘Fitbit of Plants’ uses AI sensors to monitor crops The startup Vivent provides growers with a technology to monitor plants’ health and thereby improve both yield and sustainability. The CHF 500 000 Tech Growth loan from the Foundation for Technological Innovation (FIT) will fund the development and launch of a new plant monitoring…
Read MoreINTERVIEW : Raphaël Conz, BioAlps vice-president
🔺 Raphaël Conz, Head of the Business Unit at the Department for the Promotion of the Economy and Innovation of the Canton of Vaud (SPE). The talent of Switzerland, in the field of life sciences, is to bring together academic research and big companies’ interests.
Read MoreSwiss voters reject ban on animal testing
Voters have rejected a complete ban on experiments on living creatures in Switzerland. The idea of putting an end to all experiments on animals in the context of research or scientific studies did not convince the Swiss citizens who voted on 13 February. 79.1% of voters rejected the popular initiative. In Western Switzerland, Geneva…
Read MoreAdaptyv Biosystems raised CHF 2.5 million in a pre-seed funding
Adaptyv Biosystems is to create the world’s largest protein design database The company, based in Biopôle in Epalinges, is active in the field of high-throughput protein synthesis and screening. Using synthetic biology and machine learning, Adaptyv Biosystems massively scales up the number of protein designs that can be explored. In two years’ time, Adaptyv…
Read MoreGenolier Innovation Hub
A new medical Innovation Hub will open in 2024 “This is not a real estate project to house the headquarters of companies, but rather a kind of hotel for companies that will come to experiment and present their innovations for 6 to 24 months. The goal is to reduce the latency between the time…
Read MoreHaya Therapeuthics closes US$ 5 Million seed extension
The Lausanne-based company will open a branch office in San Diego to continue its growth HAYA closes US$ 5 Million seed extension led by Humboldt Fund to advance the development of its anti-fibrotic lead program targeting Wisper, a cardiac long non-coding RNA. In May 2021, the company also announced the closing of a US$…
Read MoreINTERVIEW : Claude Clément, BioAlps President
🔺 Claude Clément is BioAlps President. According to him, multiculturality is why Switzerland🇨🇭 has become so successful in the field of life sciences.
Read MoreScience first, politics second
The “Stick to Science” petition aims to allow Swiss and British researchers to remain in Horizon Europe programme. The Stick to Science initiative has been set up by a coalition of 140 British universities and by the Polytechnic schools of Lausanne and Zurich (EPFL and EPFZ). They are calling for open and barrier-free collaboration…
Read MoreAn implant could cure paralysis
A new implant enables patients with a complete spinal cord injury to stand, walk and even swim Michel Roccati, an Italian patient suffering from complete paraplegia following a motorcycle accident, was able to walk again thanks to an implant placed against his spinal cord. Grégoire Courtine, neuroscientist and professor at the EPFL, and Jocelyne…
Read More